GENE ONLINE|News &
Opinion
Blog

2017-11-07|

November 8, 2012: Completion of the Liver Cancer Genome

by GeneOnline
Share To
Victor Ambros discovered that the lin-4 gene produces a microRNA that negatively regulates the lin-14 gene, while Gary Ruvkun cloned the lin-14 gene and together they found that the lin-4 microRNA binds to a matching sequence in lin-14's mRNA to inhibit its function.

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide. The whole genome sequence of HCC was completed by RIKEN, a Japanese research institution, and was published on November 8, 2012. The result revealed many new cancer-associated genes, a variety of genomic alterations, and the common integration sites for hepatitis B virus (HBV) genome. The report was a step forward for studying the HBV virus and for developing new drugs for liver cancer.

Reference

https://www.ncbi.nlm.nih.gov/pubmed/23142287

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
The FDA Expands Use for Gilead Science’s HBV Treatment
2022-11-02
M&A
Xbiome Acquires Ulcerative Colitis Program from Assembly Biosciences
2022-04-29
R&D
Shionogi, NEC Team Up on Hepatitis B Vaccine
2022-04-20
LATEST
2024 Nobel Prize in Medicine: Uncovering the Secrets of microRNA in Gene Regulation
2024-10-08
Sciwind Biosciences Announces Oral Presentation on Oral GLP-2 Research Progress at the 32nd United European Gastroenterology Week (UEG Week 2024)
2024-10-07
Bio Japan 2024 and Medical Japan 2024 Unleashing Innovation in Biopharmaceuticals and Healthcare Technologies
2024-10-07
Starboard Value Takes $1 Billion Stake in Pfizer, Eyes Major Overhaul
2024-10-07
Generative AI Makes its Debut in Smart Healthcare with NVIDIA Experts at the Helm
2024-10-04
How TCELS is Moving Thailand’s Biotech Industries From Local to Global
2024-10-04
Lilly Invests $4.5B in Indiana Facility for In-House Clinical Manufacturing
2024-10-03
EVENT
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
2024-10-28
BioFuture 2024
New York, U.S.A.
2024-10-30
AusBiotech 2024
Melbourne, Australia
2024-11-04
BIO-Europe 2024
Stockholm, Sweden
Scroll to Top